|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||0.6911 - 0.7288|
|52 Week Range||0.3279 - 1.3100|
|Beta (3Y Monthly)||2.47|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Canadian cannabis producer Aurora Cannabis Inc (NYSE: ACB) announced Monday that Health Canada has granted its extraction technology partner Radient Technologies Inc (OTC: RDDTF) a standard processing license. Radient identified a process to extract cannabis and hemp at large-scale volumes without risking the quality of the plant, according to Aurora. Aurora said it became aware of Radient's technology and its potential to disrupt the market in 2016.
OTCQX: RDDTF) announces today the following changes to its Board of Directors. Radient believes Mr. Cleiren will be a valuable addition to the Company as it moves forward with the commercial production of cannabinoid extracts and products, along with the global expansion of its operations. Concurrent to the appointment of Mr. Cleiren to Radient’s Board of Directors, the Company also announces that Mr. Terry Booth is stepping down from Radient’s Board of Directors, effective today.
OTCQX: RDDTF) is pleased to announce it has received its Standard Processing License from Health Canada under the new Cannabis Act regulations, which came into force on October 17, 2018. Processing of cannabis biomass in order to extract cannabinoids including CBD and THC will now begin at Radient’s recently expanded manufacturing facility (“Edmonton I Facility”) located at 4035 101 St NW in Edmonton, Alberta. This will create new revenue streams for the Company, as it begins supplying premium grade cannabis extracts and cannabinoid ingredients to its partners, including Aurora Cannabis Inc.
NEW YORK and TORONTO , Jan. 11, 2019 /PRNewswire/ -- The Canadian Securities Exchange (CSE), a Canadian listing exchange recognized as a Qualified Foreign Exchange in the U.S., Kapoor Kapital, and OTC ...
OTCQX: RDDTF) is pleased to announce that it has now filed an additional 9 provisional patent applications with the United States Patent and Trademark Office (the “USPTO”), bringing the total number of patent applications filed by the Company in 2018 to 40. The inventions covered in these patent applications relate to methods and systems for improving the safety, potency, flavour, and experience of cannabinoid extracts used in the manufacturing of food & beverage products.
OTCQX: RDDTF) is pleased to announce that its common shares commenced trading today on the OTCQX Best Market under the symbol “RDDTF”. Radient’s common shares will continue trading on the TSX Venture Exchange under the symbol “RTI”. Dorsey & Whitney LLP acted as the Company’s OTCQX Best Market sponsor and advisor.
NEW YORK , Dec. 18, 2018 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced Radient Technologies Inc. (TSX-V: RTI; ...
Up over 2,900% in two years, this marijuana stocks' proprietary extraction technology is unparalleled -- but so is its breakneck valuation.